Form 8-K - Current report:
SEC Accession No. 0001193125-24-255185
Filing Date
2024-11-12
Accepted
2024-11-12 08:01:53
Documents
13
Period of Report
2024-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d810986d8k.htm   iXBRL 8-K 32227
  Complete submission text file 0001193125-24-255185.txt   160947

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA spry-20241109.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE spry-20241109_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spry-20241109_pre.xml EX-101.PRE 11706
15 EXTRACTED XBRL INSTANCE DOCUMENT d810986d8k_htm.xml XML 3773
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 241443514
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)